Sanofi (EPA:SAN)
France
· Delayed Price · Currency is EUR 82.93
-0.25 (-0.30%)
Aug 14, 2025, 3:55 PM CET
Sanofi Revenue
Sanofi had revenue of 10.74B EUR in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 45.74B, up 15.65% year-over-year. In the year 2024, Sanofi had annual revenue of 44.29B with 7.73% growth.
Revenue (ttm)
45.74B
Revenue Growth
+15.65%
P/S Ratio
2.22
Revenue / Employee
551.87K
Employees
82,878
Market Cap
101.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.29B | 3.18B | 7.73% |
| Dec 31, 2023 | 41.11B | 805.00M | 2.00% |
| Dec 31, 2022 | 40.30B | 1.13B | 2.88% |
| Dec 31, 2021 | 39.18B | 1.81B | 4.83% |
| Dec 31, 2020 | 37.37B | -262.00M | -0.70% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 10.59M |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |
Sanofi News
- 1 hour ago - Sanofi gets EU orphan designation for rilzabrutinib - Seeking Alpha
- 9 hours ago - Press Release: Sanofi's rilzabrutinib earns orphan designation in the EU for IgG4-related disease - GlobeNewsWire
- 9 hours ago - Press Release: Sanofi's rilzabrutinib earns orphan designation in the EU for IgG4-related disease - Benzinga
- 1 day ago - UK Government, Eli Lilly Partner To Target Obesity Health Gaps - Benzinga
- 2 days ago - Sanofi reportedly halts sales of cholesterol drug Praluent in China amid limited availability - Seeking Alpha
- 2 days ago - Sanofi stops supply of high cholesterol drug to China due to limited availability - Reuters
- 6 days ago - Sanofi: Playing To Win - Seeking Alpha
- 7 days ago - Emcure Pharmaceuticals Reports Strong Q1 FY26 Results with 16% Revenue Growth and 41% Jump in Profit - Business Upturn